Studies of cerebral blood flow and metabolism in depression using positron emission tomography (PET);Badania metabolizmu i przepływu mózgowego krwi w depresji za pomoca̧ pozytronowej tomograffi emisyjnej (PET)

Psychiatria Polska

Volumn 36, Issue 4, 2002, Pages 617-628

  Jaracz, Jan ^a   Rybakowski, Janusz ^a  

^a Poznan University of Medical Sciences   (Poland)

Author keywords

Depression; Positron emission tomography

Indexed keywords

ANTIDEPRESSANT AGENT;

BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN REGION; CINGULATE GYRUS; DEPRESSION; EMOTION; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; LONELINESS; NORMAL HUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHOTHERAPY; REVIEW; THALAMUS NUCLEUS;

CEREBROVASCULAR CIRCULATION; DEPRESSION; HUMANS; LIMBIC SYSTEM; NEURAL PATHWAYS; PREFRONTAL CORTEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036034405     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Pardo JV, Pardo PJ, Raichle ME. Neural correlates of self-induced dysphoria. Am. J. Psychiatry 1993; 150: 713-719.
2. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM. Brain activity during transient sadness and happiness in healthy women. Am. J. Psychiatry 1995; 152: 341-351.
3. Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson RJ. Neuroanatomical correlates of happiness, sadness, and disgust. Am. J. Psychiatry 1997; 154: 926-933.
4. Paradiso S, Robinson RG, Andreasen NC, Downhill JE, Davidson RJ, Kirchner PT, Watkins GL, Boles Ponto LL, Hichwa RD. Emotional activation of limbic circuitry in elderly normal subject in a PET study. Am. J. Psychiatry 1997; 154: 384-389.
5. Baxter LR, Phelpes ME, Maziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders: Studies with positron emission tomography and fluorodeoxyglucose F18. Arch. Gen. Psychiatry 1985; 42: 441-447.
6. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry 1989; 46: 243-250.
7. Hurwitz TA, Clark C, Murphy E, Klonoff H, Martin WRW, Pate BD. Regional cerebral glucose metabolism in major depressive disorder Can. J. Psychiatry 1990; 35: 694-688.
8. Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, Pappata S, Syrota A. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am. J. Psychiatry 1990; 147: 1313-1317.
9. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, Reynolds C. Effects of sertraline on regional metabolic rate in patients with affective disorder. Biol. Psychiatry 1997; 41: 15-22.
10. Drevets WC, Price JL, Simpson J. Subgenualprefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-827.
11. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA. Subgenual cingulate cortex volume in first-episode psychosis. Am. J. Psychiatry 1999; 156: 1091-1093.
12. Baxter LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Swelin CE. Local cerebral glucose metabolic tates in obsessive-compulsive disorder - A comparison with rates in unipolar depression and in normal controls. Arch. Gen. Psychiatry 1987; 44: 211-218.
13. Biver F, Goldman S, Delvenne V, Luxen A, DeMaertelear V, Hubain P, Mendlewicz J, Lostra F. Frontal and parietal metabolic disturbances in unipolar depression. Biol. Psychiatry 1994; 36: 381-388.
14. Drevets WC, Videen TO, Price JL, Prescorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. J. Neurosci. 1992; 12: 3628-3641.
15. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster J.L, Fox PT. Reciprocal limbic-corticalfunction and negative mood: Converging PET findings in depression and normal sedness. Am. J. Psychiatry 1999; 156: 675-682,
16. Abercrombie HC, Schaffer SM, Larson CL, Oakes TR, Lingren KA, Holden JE, Pearlman SB, Turski PA, Krahn DD, Benka RM, Davidson RJ, Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neurorep. 1998; 9: 3301-3307.
17. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RH, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Day H, Soufer D, Harney DS. Positron emission tomography measurements of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch. Gen. Psychiatry 1997; 54: 346-374.
18. 18F]FDG PET studies. Psychiatry Res. Neuroimaging 1999; 91: 59-78.
19. Price JL, Carmichael ST, Drevets WC. Networks related to the orbital and medial prefrontal cortex: A substratefor emotional behavior? W: Holstege G, Bandler R, Saper CB, red. Progress in Brain Research: The Emotional Motor System. 1996; 107: 523-536.
20. Mayberg HS. Frontal lobe dysfunction in secondary depression. J. Psychiatry Clin. Neurosci. 1994; 46: 243-250.
21. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RSJ, Dolan RJ. Depression in Parkinson's disease. A positron emission study. Brit. J. Psychiatry 1994; 165: 333-339.
22. Mayberg H, Starkstein SE, Peyser CE, Brandt J, Dannal s RF, Folstein SE. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurol. 1992; 42: 1791-1797.
23. Elliott R, Baer SC, Rogers RD, O'Leary DA, Paykel ES, Fritf CD, Dolan RJ, Sahakian BJ. Prefrontal dysfunction in depressed patients performing a complex planning task: A study using positron emission tomography. Psychol. Med. 1997; 27: 931-943.
24. Baker SC, Frith CD, Dolan RJ. The interaction between mood and cognitive function studied with PET. Psychol. Med. 1997; 27: 565-578.
25. George MS, Ketter TA, Parekt PI, Rosinsky N, Ring HA, Pazzaglia PJ, Marangell LB, Callahan AM, Post RM. Blunted left cingulated activation in mood disorder subject during a response interference task [the stroop]. J. Neuropsychiatry Clin. Neurosc. 1997; 9: 55-63.
26. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekel JL, Cingulate function in depression: A potential predictor of treatment response. Neurorep. 1997; 8: 1057-1061.
27. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. Regional metabolic effect of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol. Psychiatry 2000; 48: 830-843.
28. Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME, Huang SC, Wu HM, Maidment K, Baxter LR. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999; 91: 127-139.
29. Brody AL, Saxena S, Mandel kern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major repressive disorder. Biol. Psychiatry 2001; 50: 171-178.
30. Bauer M, London E, Berman S, Rasgon NL, Mandelkern M, Frye MA, Altshuler LL Effects of Supraphysiological Tyroxin on Cerebral Glucose Metabolism in Bipolar Depression: A PET Study (praca wygłoszona podczas zjazdu Amerykańskiego Towarzystwa Psychiatrycznego w Nowym Orleanie w 2001 r.).
31. Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang S-Ch, Wu H-M, Ho ML, Au SC, Maindment K, Baxter LR. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy. Arch. Gen. Psychiatry 2001; 578: 631-640.
32. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA. The functional neuroanatomy of placebo effect. Am. J. Psychiatry 2002; 159: 728-737.
33. Cummings JL. Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993; 50: 873-880.
34. Nemeroff CB, Klist CD,Berns GS. Functional brain imaging: Twenty-first century phrenology or psychobiological advance for the millennium. Am. J. Psychiatry 1999; 156: 671-673.